Advertisement

Topics

Correction to Modifying Self-Assembled Peptide Cages To Control Internalization into Mammalian Cells.

08:00 EDT 11th April 2019 | BioPortfolio

Summary of "Correction to Modifying Self-Assembled Peptide Cages To Control Internalization into Mammalian Cells."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Nano letters
ISSN: 1530-6992
Pages:

Links

DeepDyve research library

PubMed Articles [13547 Associated PubMed Articles listed on BioPortfolio]

Transformation of Imine Cages to Hydrocarbon Cages.

In contrast to organic cages which are formed by exploiting dynamic covalent chemistry, such as boronic ester cages, imine cages or disulfide cages, those with a fully carbonaceous backbone are rarer....

Amino acid conformations control the morphological and chiral features of the self-assembled peptide nanostructures: Young investigators perspective.

A variety of nanostructures with different chiral features can be self-assembled from short peptides with highly similar sequences. We hypothesize that these supramolecular nanostructures are ruled by...

A peptide derived from phosphoinositide 3-kinase inhibits endocytosis and influenza virus infection.

Endocytosis mediates the internalization and ingestion of a variety of endogenous or exogenous substances, including virus particles, under the control of intracellular signaling pathways. We have pre...

DNA Translocation through a Nanopore in Ultrathin Self-assembled Peptide Membrane.

Here, we explore the possibility of using peptide-based materials as a membrane in solid-state nanopore devices as an effort to develop a sequence-specific, programmable biological membrane platform. ...

Embedding and positioning of two FeII4L4 cages in supramolecular tripeptide gels for selective chemical segregation.

An unreported D,L-tripeptide self-assembled into gels that embedded FeII4L4 metal-organic cages, forming materials that were characterized by TEM, EDX, Raman, rheometry, UV-Vis, NMR and circular dichr...

Clinical Trials [3867 Associated Clinical Trials listed on BioPortfolio]

Prospective Follow-up Study of Titanium-Coated PEEK Cages for Degenerative Disc Disease

Prospective Follow-up study of CeSPACE XP coated PEEK cages for the treatment of degenerative cervical disc disease

Percutaneous Externally-Assembled Laparoscopic Urologic Surgery

This will be a single-arm prospective internally-controlled study. Patients will undergo percutaneous externally-assembled laparoscopic surgery where one or more 3 mm instruments are added...

Lumbar Fusion With Nexxt Spine 3D-Printed Titanium Interbody Cages

The purpose of this randomized controlled trial is to assess and compare radiographic and clinical outcomes in patients who are to undergo combined interbody/posterolateral lumbar fusion p...

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

To evaluate the chemical efficacy and safety of intranasally administered peptide T on neurocognitive function in HIV seropositive individuals. Previous studies have shown that treatment ...

Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT)

The overall objective of this study is to investigate the glycemic response of a 0%, 50%, 100% and 150% bolus insulin correction (based on personal insulin correction factor) of post-exerc...

Medical and Biotech [MESH] Definitions

A receptor activity-modifying protein that is a subunit of specific G-PROTEIN COUPLED RECEPTORS. The CALCITONIN GENE-RELATED PEPTIDE RECEPTOR is formed from a dimer of this protein and CALCITONIN RECEPTOR-LIKE PROTEIN, while an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.

A receptor protein that is associated with RECEPTOR ACTIVITY-MODIFYING PROTEINS. When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 1 it forms the CALCITONIN GENE-RELATED RECEPTOR. When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 2 or RECEPTOR ACTIVITY-MODIFYING PROTEIN 3 it forms the ADRENOMEDULLIN RECEPTOR.

The production of PEPTIDES or PROTEINS by the constituents of a living organism. The biosynthesis of proteins on RIBOSOMES following an RNA template is termed translation (TRANSLATION, GENETIC). There are other, non-ribosomal peptide biosynthesis (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT) mechanisms carried out by PEPTIDE SYNTHASES and PEPTIDYLTRANSFERASES. Further modifications of peptide chains yield functional peptide and protein molecules.

A 36-amino acid peptide produced by the L cells of the distal small intestine and colon. Peptide YY inhibits gastric and pancreatic secretion.

A receptor activity-modifying protein that heterodimerizes with CALCITONIN RECEPTOR-LIKE PROTEIN to form the ADRENOMEDULLIN RECEPTOR. In addition, an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Searches Linking to this Article